You get it from vendors, that is all.
I was wondering, Kat do you think this statement is false?
"This drug will be nothing special. It will have little to no euphoria whatsoever (though some people actually do report mild euphoria from selective serotonin releasers like MDAI, but it will not be anything like a stimulant in terms of reward) and it will be controlled under analogue laws in various countries. Based on SAR studies it should be a shitty releaser of serotonin (versus reuptake inhibitor; analogy: MDA vs MDMA) and a weak psychedelic. The lack of an N-methyl group is what fucks up the serotonin release, so I would say methylate it and you'll have a decent 5-HT releaser, but predicamentally N-methylation also essentially abolishes psychedelic activity. So you have to choose between 5-methyl-MDA and N-methyl-5-methyl-MDA, the former being a crappy serotonin releaser + weak psychedelic and the latter being a pure and efficacious serotonin releaser but lacking of any hallucinogenic effects. I would personally go with the latter.
The best comparison of another drug to 5-methyl-MDA I can think of would probably be IAP, but without even the weak catecholaminergic effects. Another analogy is low dose 2C-x + MDAI. I really do not think anyone is going to desire this compound once it has been assayed, similarly to what happened to IAP years back. Vendors, you seriously need to learn a thing or two about pharmacology. You are wasting your time on this one. And essentially anything with the word "amphetamine" in its name is going to be controlled under analogue laws in the US and UK (and others), so why are you even touching this compound in the first place?"